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Sunday, February 26, 2012 111acultures of human airway smooth muscle cells endogenously expressing
GABAA channels composed of a4, a5 b3 g1, g2, d and q subunits. We obtained
success rates above 95% for transiently or stably transfected HEK cells and fro-
zen ‘‘ready to assay’’ HEK cells expressing GABAA channels. Tissue-derived
immortalized cultures of airway smooth muscle cells exhibited a slightly lower
recording success rate of 75% using automated patch, which was much higher
than the 5% success rate using manual patch clamp. Primary cells harvested
from tissue yielded 30% success on this automated electrophysiology platform.
In all cases, both responses to agonist (EC50 measurements) and pharmacology
of GABAmodulators and inhibitors compared well to previously reported man-
ual patch results. The data presented here demonstrates that both the biophysics
and pharmacologic characterization of GABAA channels in a wide variety of
cell formats can be performed on this automated patch clamp system. This au-
tomated approach exhibited a much higher success rate, lower variability, and
higher experimental throughput as compared to manual patch clamp
techniques.
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Missense polymorphisms or variants that affect function and/or expression of
GABAA receptors (GABARs) have been associated with idiopathic generalized
epilepsies (IGEs) in GABRA1, GABRA6, GABRB3, GABRG2 and GABRD
genes. Three separate IGE-associated mutations were identified in GABAR
subunits (b3(G32R), a6(Q237R) and g2(K328M)), which represent a large
range of GABARs in the nervous system. We sought to investigate the contri-
butions of these mutations into the assembly and function of GABARs. Homol-
ogy modeling suggested that G32R is located within the N-terminal a-helix b3
subunit domain, and Q237R and K328M are located within the pre-M1 segment
of the N-terminal a6 subunit domain and the M2-M3 loop of the N-terminal g2
subunit domain, respectively. We studied gating properties and surface expres-
sion of wild type (wt) a1b3g2, a6b2g2, a1b2g2 and mutant a1b3(G32R)g2,
a6(Q237R)b2g2, a1b2g2(K328M) receptors expressed in HEK293T cells.
We found that the mutations share common gating defects, but distinctive traf-
ficking defects. Thus, mutant b3(G32R) subunits displayed a mixed profile,
causing both gating and trafficking defects of a1b3g2 receptors, whereas mu-
tant a6(Q237R) and g2(K328M) subunits caused exclusive channel gating de-
fects of a6b2g2 and a1b2g2 receptors. Unexpected, homology modeling
predicted that the b3(G32R) mutation affects a salt bridge across the g2/b3 sub-
unit interface, which underlies an assembly motif reported to be essential for
inter-subunit interactions in assembled receptors. In contrast, a6(Q237R) and
g2(K328M) subunit mutations are predicted to interact with residues in Pre-
M1 domain, M2-M3 loop and Cys-loop of a6 and g2 subunits that are critical
for desensitization-deactivation coupling of GABARs.
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A new model for the gamma-aminobutyric acid class A (GABAa) receptor is
presented, based on recent crystal structures of the homologous eukaryotic
GluCl channel (3RHW). The models suggest an additional disulfide bridge in
the transmembrane domain of both alpha and gamma (but not beta) subunits.
Models for the GABAa receptor in complex with steroid or steroid-like mod-
ulators such as cholesterol, pregnenolone, and thyroid hormone have also
been developed, based on ivermectin sites in PDB:3RHW and mutagenesis
studies. Extended molecular dynamics simulations of these models indicate sta-
ble binding interactions between the modulator and the receptor, with moderate
adjustment of modulator orientation. Hydrogen bonding patterns between mod-
ulator and receptor polar groups are shown to be modulator-dependent; these
results will be compared to prevailing hypotheses for essential pharmacophores
in modulation of GABAa receptors by neurosteroids.
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Massachusetts, Amherst, Amherst, MA, USA.GABA is the main inhibitory neurotransmitter in the brain, acting primarily at
ionotropic GABAA receptors. The a subunit is critical in determining GABAA
receptor functional properties and pharmacological regulation. There are six
a subunit subtypes that are differentially expressed in the nervous system but
few selective antagonists are available to dissect the functional role of those
subtypes in neurons. We have therefore engineered a subunit specific light in-
hibited GABAA receptors (Li-GABARs). We generated a subunits with a cys-
teine mutation that allows attachment of a photoswitchable tethered ligand
(PTL) consisting of a cysteine reactive maleimide group, a photoisomerizable
azobenzene core and a variable GABAR ligand. Using cysteine-scanning mu-
tagenesis we identified optimal photoswitch attachment sites near the GABA
binding pocket for both a1 and a5 subunits, and tested multiple PTLs to pro-
duce maximal light dependent block of GABAR activity while minimally af-
fecting basal receptor properties. We recorded from hippocampal slices
expressing Li-GABARs and found evidence that a5, but not a1 containing re-
ceptors counteract NMDA receptor dependent synaptic depolarization. This
novel interaction could provide a basis for the regulation of synaptic plasticity
and memory by a5 receptors. This approach in general provides a strategy to
study the role of specific GABAA receptor subunits and their importance in
neuronal function and disease.
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GABAA-receptors (GABARs) are chloride ion channels in the ‘cys-loop recep-
tor’ superfamily that are major inhibitory neuroreceptors. Upon agonist binding,
GABARs open and increase intraneuronal chloride ion concentration, hyperpo-
larize the cell and inhibit neural transmission. Reducing agents will break the di-
sulfide bonds in the cys-loop of the receptor. Indeed, it has been speculated that
sulfhydryl compounds modify proteins via thiol/disulfide redox reactions and
serve as neuromodulators (1). Reducing reagents were found to decrease the
GABA EC50 in the highly homologous GABAC-receptor, while oxidizing
reagents increased the EC50 (2). Conversely, conflicting findings suggests the
mechanism of action of redox modulation does not alter GABAR agonist-
binding affinity (3). However, studies are complicated by the fact that mutagen-
esis of the cysteines commonlyproduces failure of subunit assembly (4). Thus, to
investigate the effect of disulfide bond breakage on the receptor we generated
various GABAR homologymodels with and without disulfide bonds. These sys-
tems were subjected to ligand docking and extensive molecular dynamics sim-
ulations to determine if the GABA affinity was modulated. This work
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GABAA receptors belong to the family of pentameric ligand-gated ion chan-
nels (LGIC), which are involved in fast inhibitory neurotransmission. GABAA
receptors are allosterically modulated by benzodiazepines, general anesthetics
and alcohols. In this study, we investigate the effects of a range of general an-
esthetics, alcohols and non-competitive inhibitors on ELIC, which is a recently
characterized prokaryote homolog of GABAA receptors. We used two-
electrode voltage clamp recordings to identify ELIC modulators from a library
of compounds including chlorpromazine, memantine, picrotoxin, etomidate,
DMCM and brominated derivatives of alcohols and chloroform. X-ray crystal
structures of ELIC in complex with different modulators reveal the molecular
architecture for ligand recognition. Consistent with the observation that
